Literature DB >> 9347685

Use of fluconazole in the treatment of non-AIDS cryptococcal meningitis.

S J Antony1, A Patel, J Leonard.   

Abstract

The treatment of non-acquired immunodeficiency syndrome (AIDS) cryptococcal meningitis has not been well defined as yet. The current recommendation is amphotericin B with or without flucytosine. However, due to the many side effects of these drugs, fluconazole is becoming an attractive alternative in patients who cannot tolerate amphotericin B and flucytosine. This case study demonstrates the successful use of fluconazole in a patient with underlying diabetes mellitus and cryptococcal meningitis.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9347685      PMCID： PMC2608247     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  8 in total

1.  Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

Authors:  M S Saag; W G Powderly; G A Cloud; P Robinson; M H Grieco; P K Sharkey; S E Thompson; A M Sugar; C U Tuazon; J F Fisher
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

Review 2.  The future of antifungal therapy.

Authors:  J R Graybill
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

3.  Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group.

Authors:  F Dromer; S Mathoulin; B Dupont; O Brugiere; L Letenneur
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

4.  A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.

Authors:  J E Bennett; W E Dismukes; R J Duma; G Medoff; M A Sande; H Gallis; J Leonard; B T Fields; M Bradshaw; H Haywood; Z A McGee; T R Cate; C G Cobbs; J F Warner; D W Alling
Journal:  N Engl J Med       Date:  1979-07-19       Impact factor: 91.245

5.  Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.

Authors:  S L Chuck; M A Sande
Journal:  N Engl J Med       Date:  1989-09-21       Impact factor: 91.245

Review 6.  Overview: treatment of cryptococcal meningitis.

Authors:  A M Sugar; J J Stern; B Dupont
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

7.  Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

Authors:  W E Dismukes; G Cloud; H A Gallis; T M Kerkering; G Medoff; P C Craven; L G Kaplowitz; J F Fisher; C R Gregg; C A Bowles; S Shadomy; A M Stamm; R B Diasio; L Kaufman; S Soong; W C Blackwelder
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

Review 8.  Management of cryptococcosis.

Authors:  W E Dismukes
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079
  8 in total
  3 in total

1.  Chronic Meningitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

2.  Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions.

Authors:  P Mwaba; J Mwansa; C Chintu; J Pobee; M Scarborough; S Portsmouth; A Zumla
Journal:  Postgrad Med J       Date:  2001-12       Impact factor: 2.401

3.  A Case of Cryptococcal Meningitis and Fungemia With Relapse in an HIV-Negative, Non-transplant Patient on Azathioprine Therapy for Mixed Connective Tissue Disorder.

Authors:  Ridwan Faruq; Lucia Plichtova; Namita Bhagat; Zane Saul
Journal:  Cureus       Date:  2022-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.